Lipid-lowering Therapy and LDL Cholesterol in Patients after acute Coronary Syndrome

被引:0
|
作者
Haider, P. [1 ]
Galli, L. [1 ]
Schrutka, L. [1 ]
Distelmaier, K. [1 ]
Wojta, J. [1 ]
Hengstenberg, C. [1 ]
Krychtiuk, K. [1 ]
Speidl, W. [1 ]
机构
[1] Med Univ Vienna, Vienna, Austria
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
13-5
引用
收藏
页码:S419 / S419
页数:1
相关论文
共 50 条
  • [1] Impact of a virtual lipid clinic on lipid-lowering therapy, LDL cholesterol levels, and outcomes in patients with acute coronary syndrome
    Garcia, Rafael Vazquez
    Garcia, Juan Enrique Puche
    Navas, William Delgado
    Salmeron, Diego Mialdea
    Mateos, Daniel Bartolome
    JOURNAL OF CLINICAL LIPIDOLOGY, 2022, 16 (05) : 635 - 642
  • [2] Lipid-Lowering Therapy after Acute Coronary Syndrome
    Pogran, Edita
    Burger, Achim Leo
    Zweiker, David
    Kaufmann, Christoph Clemens
    Muthspiel, Marie
    Rega-Kaun, Gersina
    Wenkstetten-Holub, Alfa
    Wojta, Johann
    Drexel, Heinz
    Huber, Kurt
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (07)
  • [3] Effectiveness of hospital lipid-lowering protocol of intensive lipid-lowering therapy for patients with acute coronary syndrome
    Nakao, Sho
    Ishihara, Takayuki
    Tsujimura, Takuya
    Iida, Osamu
    Hata, Yosuke
    Toyoshima, Taku
    Higashino, Naoko
    Mano, Toshiaki
    JOURNAL OF CARDIOLOGY, 2022, 79 (03) : 391 - 399
  • [4] LDL apheresis as intensive lipid-lowering therapy for cholesterol embolism
    Tsunoda, S
    Daimon, S
    Miyazaki, R
    Fujii, H
    Inazu, A
    Mabuchi, H
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (04) : 1041 - 1042
  • [5] Update on lipid-lowering therapy and LDL-cholesterol targets
    Stephen D Wiviott
    Christopher P Cannon
    Nature Clinical Practice Cardiovascular Medicine, 2006, 3 : 424 - 436
  • [6] Update on lipid-lowering therapy and LDL-cholesterol targets
    Wiviott, Stephen D.
    Cannon, Christopher P.
    NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2006, 3 (08): : 424 - 436
  • [7] The Lipid-Lowering Effect of Atorvastatin in Acute Coronary Syndrome Patients
    Ying, Ku Ming
    Tan, S. S. N.
    Tan, C. S. Y.
    Tiong, L. L.
    Lim, A. M. W.
    Ling, D. E.
    Hii, E. H. H.
    Kiu, I. S. N.
    Wong, L. W.
    Ting, M. L. L.
    Sumbai, M. E.
    Chua, A. T. P.
    Douglas, J. S.
    Theng, M. L.
    Chew, S. W.
    Fong, A. Y. Y.
    Ong, T. K.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 273 : 7 - 8
  • [8] Lipid-lowering therapy modification and LDL-C Goal achievement after an acute coronary syndrome: a prospective Swiss cohort
    Gencer, B.
    Mach, F.
    Auer, R.
    Raeber, L.
    Nanchen, D.
    Meyer, P.
    Matter, C. M.
    Windecker, S.
    Luescher, T. F.
    Rodondi, N.
    EUROPEAN HEART JOURNAL, 2013, 34 : 136 - 136
  • [9] INTENSITY OF LIPID-LOWERING THERAPY, ADHERENCE AND LDL-CHOLESTEROL GOAL ATTAINMENT IN PATIENTS WITH CORONARY HEART DISEASE
    Mazhar, F.
    Hjemdahl, P.
    Clase, C. M.
    Johnel, K.
    Jernberg, T.
    Carrero, J. J.
    ATHEROSCLEROSIS, 2022, 355 : E301 - E301
  • [10] Lipid-lowering therapy in acute coronary syndromes
    Sacks, FM
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (13): : 1758 - 1760